FDA Clearance Tracker · P040044-S097
MYNX CONTROL Venous Vascular Closure Device (VCD) 6F-12F
Last checked: Nov 20, 2026Latest source record: Jun 27, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jun 27, 2024
Approved
Time to decision
210 days
Received Nov 30, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P040044-S097
- Device name
- MYNX CONTROL Venous Vascular Closure Device (VCD) 6F-12F
- Applicant
- Cordis US Corporation
- Applicant location
- Miami Lakes, FL
- Received
- Nov 30, 2023
- Decided
- Jun 27, 2024
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P040044
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the MYNX CONTROL Venous Vascular Closure Device (VCD) 6F-12F for expanding the indications to include venous multiple access closure.
Source documents
Other decisions for Cordis US Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PRECISE PRO RX Transcarotid Stent SystemPMA supplement
P030047-S049 · Decided Apr 4, 2025 · 185 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
P150002 · Decided Nov 27, 2018 · 1,412 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.